{"filing":{"accession_number":"0001493152-26-035913","cik":"0001535955","ticker":"LPCN","company_name":"Lipocine Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226035913/form8-k.htm"},"events":[{"id":23521,"run_id":21262,"accession_number":"0001493152-26-035913","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing financial results for the quarter ended June 30, 2026. The filing includes detailed quarterly and six-month financial statements showing net losses, revenue, and operating expenses, along with a corporate update on clinical development programs. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":23769,"accession_number":"0001493152-26-035913","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing financial results for the quarter ended June 30, 2026. The filing includes detailed quarterly and six-month financial statements showing net losses, revenue, and operating expenses, along with a corporate update on clinical development programs. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T10:12:03.540154+00:00","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-08-04"}]}
